Ziihera

zanidatamab-hrii

Approval

ApplicationBLA 761416
Approval dateNov 20, 2024
Approval year2024
SponsorJazz Pharms

FDA-approved use

To treat unresectable or metastatic HER2-positive (IHC 3+) biliary tract cancer

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Ziihera: